100mg Paclitaxel Protein Bound Particles Injection



500mg Rituximab Injection IP

500mg Rituximab Injection

400mg Bevacizumab Concentrate Injection

400mg Bevacizumab Injection

500mg Capecitabine Tablet

150mg Erlotinib Tablets

400mg Pazopanib Tablets

160mg Megestrol Acetate Tablets IP

500mg Capecitabine Tablets

125mg Palbociclib Capsules

100mg Acalabrutinib Capsules

250mg Temozolomide Capsules IP

25mg Lenalidomide Capsules

10mg Lenalidomide Capsules

Chiro Guard IV Codan Vented Infusion Set

Polygrip Huber Y Infusion Set

Mercaptopurine Oral Suspension Powder

Progesterone Vaginal Gel
Established in 2024, Gir Pharma Research And Healthcare LLP is a trusted name in the pharmaceutical industry, committed to advancing healthcare through innovation and quality. Operating as a proprietor firm, we specialize in providing a wide range of high-quality pharmaceutical products and services.Our offerings include Rituximab Injections, Bevacizumab Injections, Trastuzumab Injections, and other life-saving medications used in the treatment of critical conditions such as cancer and autoimmune disorders. We pride ourselves on maintaining stringent quality standards and ensuring timely delivery of our products to meet the evolving needs of the healthcare sector.At Gir Pharma, our mission is to make advanced healthcare accessible and affordable. We are driven by a commitment to excellence, customer satisfaction, and ethical business practices, aiming to build long-term partnerships with hospitals, clinics, and healthcare professionals across the region.
+918043878278
Loading...
| HSN Code | HSN Description |
|---|---|
| 30049049 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale other : anticancer drugs : other |
| 3002 | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products |